Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMobeus I&g 2 Regulatory News (MIG)

Share Price Information for Mobeus I&g 2 (MIG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 59.00
Bid: 57.50
Ask: 60.50
Change: 0.00 (0.00%)
Spread: 3.00 (5.217%)
Open: 59.00
High: 59.00
Low: 57.50
Prev. Close: 59.00
MIG Live PriceLast checked at -
Mobeus Income & Growth 2 VCT is an Investment Trust

To provide investors with a regular income stream, arising both from the income generated by companies selected for the portfolio and from realising any growth in capital, while continuing at all times to qualify as a VCT.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

12 Sep 2023 10:30

RNS Number : 1745M
Mobeus Income & Growth 2 VCT PLC
12 September 2023
 

MOBEUS INCOME & GROWTH 2 VCT PLC

("the Company")

LEI: 213800LY62XLI1B4VX35

 

INTERIM MANAGEMENT STATEMENT

For the quarter ended 30 June 2023

 

Mobeus Income & Growth 2 VCT plc presents an Interim Management Statement for the quarter ended 30 June 2023. The statement also includes relevant financial information between the end of the period and the date of this statement.

 

NET ASSET VALUE AND TOTAL RETURN PER SHARE

 

At 30 June 2023

(unaudited)

At 31 March 2023

(audited)

Net assets attributable to shareholders

£71,597,619

£70,426,557

Shares in issue

98,437,045

98,437,045

Net asset value (NAV) per share

72.73p

71.54p

Cumulative dividends paid

147.00p

147.00p

Cumulative Total return (net asset value basis) per share since inception

219.73p

218.54p

 

Net asset value (NAV) per share has increased by 1.19 pence, or 1.7% over the period. This increase is primarily due to a rise in unrealised valuations over the first three months of the financial year. No dividends have been paid in the period.

 

INVESTMENT ACTIVITY DURING THE PERIOD

 

New Investments

On 3 May 2023, a new equity investment of £0.39 million was made into Dayrize B.V., a provider of a rapid sustainability impact assessment tool.

 

Share Buybacks

No shares were bought back in the quarter.

 

 

INVESTMENT ACTIVITY AFTER THE PERIOD END

 

New investments after the period end

On 26 July 2023, a new equity investment of £0.32 million was made into Mable Therapy Limited, a digital health platform for speech therapy and counselling for children and young adults.

 

On 3 August 2023, a new equity investment of £0.32 million was made into Branchspace Limited, a digital retailing consultancy and software provider to the aviation and travel industry.

 

Follow-on investments after the period end

On 4 July 2023, a follow on equity investment of £0.30 million was made into Legatics Holdings Limited, a SaaS LegalTech software provider.

 

On 11 August 2023, a follow on loan investment of £0.11 million was made into Orri, an intensive day care provider for adults with eating disorders.

 

Share Buybacks after the period end

On 18 July 2023, the Company purchased 336,876 of its own ordinary shares at a price of 67.96 pence per share.

 

All shares bought back by the Company were subsequently cancelled.

 

 

Please note that all of the above information is unaudited.

 

Other than as described above, there were no material events during the period and to the date of this announcement.

 

For further information, please contact:

Gresham House Asset Management Limited,

Company Secretary

020 7382 0999

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCKLLBFXKLLBBX
Date   Source Headline
2nd Apr 20249:30 amRNSTotal Voting Rights and Capital
28th Mar 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
4th Mar 202410:00 amRNSTransaction in Own Shares and Total Voting Rights
1st Mar 202411:00 amRNSTotal Voting Rights and Capital
28th Feb 20243:30 pmRNSMerger Discussions
27th Feb 20242:00 pmRNSRealisation of Investment: Master Removers Group
21st Feb 20247:00 amRNSInterim Management Statement
20th Feb 20243:00 pmRNSDividend Declaration
1st Feb 202411:42 amRNSVoting Rights and Capital
23rd Jan 202412:45 pmRNSDirector Declaration - Non-Executive Appointment
22nd Jan 20242:00 pmRNSTransaction in Own Shares and Total Voting Rights
2nd Jan 20241:00 pmRNSVoting Rights and Capital
21st Dec 202310:00 amRNSTransaction in Own Shares
1st Dec 20237:00 amRNSTotal Voting Rights
30th Nov 20237:00 amRNSINTERIM RESULTS TO 30 SEPTEMBER 2023
1st Nov 20237:00 amRNSTotal Voting Rights
12th Oct 20237:00 amRNSStatement re Change of Registrar
2nd Oct 20237:00 amRNSTotal Voting Rights
27th Sep 20231:00 pmRNSTransaction in Own Shares
13th Sep 202312:15 pmRNSResult of AGM
13th Sep 202311:46 amRNSDividend Declaration - Replacement
13th Sep 202310:00 amRNSDividend Declaration
12th Sep 202310:30 amRNSInterim Management Statement
1st Sep 20237:00 amRNSTotal Voting Rights
1st Aug 20237:00 amRNSTotal Voting Rights
26th Jul 20232:30 pmRNSInvestment Adviser Co-investment Incentive Scheme
19th Jul 20233:00 pmRNSTransaction in Own Shares
13th Jul 20237:00 amRNSAnnual Financial Report
3rd Jul 20237:00 amRNSTotal Voting Rights
1st Jun 20237:00 amRNSTotal Voting Rights
2nd May 202310:00 amRNSTotal Voting Rights
3rd Apr 20237:00 amRNSTotal Voting Rights
29th Mar 202310:00 amRNSTransaction in Own Shares
27th Mar 20231:00 pmRNSRealisation of investment: Tharstern Group Limited
7th Mar 20237:30 amRNSTransaction in Own Shares
1st Mar 20237:00 amRNSTotal Voting Rights
22nd Feb 20233:32 pmRNSDividend Declaration
7th Feb 20235:00 pmRNSInterim Management Statement
6th Feb 20235:25 pmRNSIssue of Equity and Total Voting Rights
1st Feb 20237:00 amRNSTotal Voting Rights
31st Jan 202311:07 amRNSIssue of Supplementary Prospectus
27th Jan 20232:00 pmRNSNet Asset Value(s)
16th Jan 20237:00 amRNSCHANGE OF ALLOTMENT DATE
11th Jan 20235:35 pmRNSTransaction in Own Shares
15th Dec 20229:36 amRNSINTERIM RESULTS TO 30 SEPTEMBER 2022
5th Dec 20224:00 pmRNSPartial realisation of investment - EOTH Limited
16th Nov 20225:52 pmRNSIssue of Equity and Total Voting Rights
8th Nov 20225:42 pmRNSTHE OFFER FOR SUBSCRIPTION IS NOW FULLY SUBSCRIBED
4th Nov 20229:50 amRNSDirectorate Change
3rd Nov 20227:00 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.